286 related articles for article (PubMed ID: 26282097)
1. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.
Nakamura T; Miyabe H; Hyodo M; Sato Y; Hayakawa Y; Harashima H
J Control Release; 2015 Oct; 216():149-57. PubMed ID: 26282097
[TBL] [Abstract][Full Text] [Related]
2. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy.
Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H
J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060
[TBL] [Abstract][Full Text] [Related]
3. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation.
Nakamura T; Sato T; Endo R; Sasaki S; Takahashi N; Sato Y; Hyodo M; Hayakawa Y; Harashima H
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34215690
[TBL] [Abstract][Full Text] [Related]
4. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.
Wang Z; Celis E
Cancer Immunol Immunother; 2015 Aug; 64(8):1057-66. PubMed ID: 25986168
[TBL] [Abstract][Full Text] [Related]
5. Identification of a negative feedback loop between cyclic di-GMP-induced levels of IFI16 and p202 cytosolic DNA sensors and STING.
Panchanathan R; Liu H; Xin D; Choubey D
Innate Immun; 2014 Oct; 20(7):751-9. PubMed ID: 24131791
[TBL] [Abstract][Full Text] [Related]
6. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
[TBL] [Abstract][Full Text] [Related]
7. Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma.
Zhang Z; Liu J; Xiao M; Zhang Q; Liu Z; Liu M; Zhang P; Zeng Y
Nano Res; 2023; 16(4):5206-5215. PubMed ID: 36405984
[TBL] [Abstract][Full Text] [Related]
8. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C
Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717
[TBL] [Abstract][Full Text] [Related]
9. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer.
Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S
Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511
[No Abstract] [Full Text] [Related]
10. Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.
An M; Yu C; Xi J; Reyes J; Mao G; Wei WZ; Liu H
Nanoscale; 2018 May; 10(19):9311-9319. PubMed ID: 29737353
[TBL] [Abstract][Full Text] [Related]
11. c-di-GMP enhances protective innate immunity in a murine model of pertussis.
Elahi S; Van Kessel J; Kiros TG; Strom S; Hayakawa Y; Hyodo M; Babiuk LA; Gerdts V
PLoS One; 2014; 9(10):e109778. PubMed ID: 25333720
[TBL] [Abstract][Full Text] [Related]
12. Novel formulation of c-di-GMP with cytidinyl/cationic lipid reverses T cell exhaustion and activates stronger anti-tumor immunity.
Yu X; Yu J; Dai H; Deng C; Sun X; Long S; Jiang Z; Jin H; Guan Z; Yang Z
Theranostics; 2022; 12(15):6723-6739. PubMed ID: 36185614
[No Abstract] [Full Text] [Related]
13. Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia.
Karaolis DK; Newstead MW; Zeng X; Hyodo M; Hayakawa Y; Bhan U; Liang H; Standiford TJ
Infect Immun; 2007 Oct; 75(10):4942-50. PubMed ID: 17646358
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Activation of cGAS for Cancer Immunotherapy.
Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
Front Immunol; 2021; 12():753472. PubMed ID: 34899704
[TBL] [Abstract][Full Text] [Related]
15. Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING.
Chin KH; Tu ZL; Su YC; Yu YJ; Chen HC; Lo YC; Chen CP; Barber GN; Chuah ML; Liang ZX; Chou SH
Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):352-66. PubMed ID: 23519410
[TBL] [Abstract][Full Text] [Related]
16. [Development of a Drug Delivery System for Cancer Immunotherapy].
Nakamura T
Yakugaku Zasshi; 2016; 136(11):1477-1484. PubMed ID: 27803478
[TBL] [Abstract][Full Text] [Related]
17. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Ohkuri T; Kosaka A; Ishibashi K; Kumai T; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2017 Jun; 66(6):705-716. PubMed ID: 28243692
[TBL] [Abstract][Full Text] [Related]
19. DNA-loaded nano-adjuvant formed with a vitamin E-scaffold intracellular environmentally-responsive lipid-like material for cancer immunotherapy.
Kawai M; Nakamura T; Miura N; Maeta M; Tanaka H; Ueda K; Higashi K; Moribe K; Tange K; Nakai Y; Yoshioka H; Harashima H; Akita H
Nanomedicine; 2018 Nov; 14(8):2587-2597. PubMed ID: 30170077
[TBL] [Abstract][Full Text] [Related]
20. Bacterial c-di-GMP is an immunostimulatory molecule.
Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F
J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
